| Literature DB >> 29877315 |
Junping Sun1, Yongjiu Xiao1, Mingyue Zhang1, Ting Ao1, Shan Lang1, Jianxin Wang1.
Abstract
BACKGROUND The aim of this study was to characterize adenovirus-associated acute respiratory infection (ARI) and observe correlations between inflammatory markers and severity of human adenovirus type 7 (HAdV-7) infection, and to evaluate the potential of inflammatory markers to predict progression from upper-respiratory infection (URI) to adenovirus pneumonia (AdP). MATERIAL AND METHODS A total of 81 patients with adenovirus-associated ARI and confirmed HAdV-7 infection were enrolled. Cases were classified according to severity, as AdP and URI. Demographic and clinical data were collected retrospectively. Clinical features and serum inflammatory markers were evaluated and compared according to the severity of adenoviral infection. RESULTS We observed high-grade fever and strong inflammatory response in patients with HAdV-7-associated ARI. Procalcitonin (PCT), interleukin 6 (IL-6), and C-reactive protein concentrations were higher in patients with AdP than in those with URI. The mean erythrocyte sedimentation rate (ESR) was significantly higher in patients with AdP (p=0.008). Reduced serum prealbumin levels were observed in patients with HAdV-7 infection. In the analysis of URI to AdP prediction ability, areas under the curve (AUCs) for all inflammatory markers were <0.9. We found that 35.9% of pneumonia had ≥2 lobars of lung infiltrate and bilateral lung infiltrate, and 20% of patients with SP had pleural effusion and atelectasis. CONCLUSIONS IL-6 and ESR were associated with the severity of HAdV-7 respiratory infection. No inflammatory marker in our study predicted URI-to-AdP progression accurately. Lung infiltration and consolidation are common in HRCT in AdP. Multiple- or single-lobar/segment consolidation was most common in SP. SP progressed very quickly after onset.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29877315 PMCID: PMC6020746 DOI: 10.12659/MSM.910692
Source DB: PubMed Journal: Med Sci Monit ISSN: 1234-1010
Clinical and laboratory characteristics of patients with adenovirus type 7 infection.
| Characteristic | All cases (n=81) | AdP (n=39) | URI (n=42) |
|---|---|---|---|
| Age (years) | 18.96±1.47 | 19.08±1.49 | 18.86±1.46 |
| Fever | 81/81 (100) | 39/39 (100) | 42/42 (100) |
| Tmax (°C) | 39.40±0.59 | 39.51±0.69 | 39.31±0.47 |
| WBC, median (IQR) (109/l) | 7.65 (2.1–19.3) | 7.73 (2.8–19.3) | 7.58 (2.1–15.5) |
| N, median (IQR) (109/l) | 5.47 (0.65–15.22) | 5.47 (0.65–15.22) | 5.47 (0.65–13.84) |
| L, median (IQR) (109/l) | 1.42 (0.61–6.41) | 1.52 (0.75–6.41) | 1.33 (0.61–3.04) |
AdP – adenovirus pneumonia; URI – upper respiratory infection; Tmax – maximum body temperature; WBC – white blood cell; IQR – interquartile range; N – neutrophil; L – lymphocyte.
Figure 1HRCT in a 22-year-old patient with SP, showing fuzzy boundaries in bilateral lung scatter with flakey/patchy infiltration. Lung lesions progressed very quickly. The double-lung patchy shadow progressed into consolidation within 4 days.
Figure 2Multiple- or single-segment consolidation was observed in HRCT and it was followed by ground-glass opacities. Ground-glass-like changes, bronchial signs, and interstitial and nodular changes are visible. Pleural effusion and atelectasis also can be observed.
The characteristics of chest radiography who developed to adenovirus pneumonia.
| Characteristics | All pneumonia cases (n=39) | SP (n=10) | CP (n=29) |
|---|---|---|---|
| No. of lobar involved ≥2 | 14 (35.9) | 6 (60.0) | 8 (27.6) |
| Bilateral infiltrate | 14 (35.9) | 6 (60.0) | 8 (27.6) |
| Pleural effusion | 2 (5.1) | 2 (20.0) | 0 (0.0) |
| Atelectasis | 2 (5.1) | 2 (20.0) | 0 (0.0) |
| Mutiple lobar or segment | 14 (35.9) | 6 (60.0) | 8 (27.6) |
| Single lobar or segment | 26 (66.7) | 4 (60.0) | 22 (75.9) |
| Consolidation and muti-focal patchy/ground glass opacities | 39 (100.0) | 10 (100.0) | 29 (100.0) |
| Patchy infiltration (single lobar) | 21 (53.8) | 4 (40.0) | 17 (58.6) |
| Diffuse ground-glass opacities | 2 (5.1) | 1 (10.0) | 1 (3.4) |
AdSP – severe pneumonia; AdP – pneumonia. Categorical variables are expressed as no. of patients with the presence of the characteristics.
Serum inflammatory marker concentrations.
| Group | PCT (ng/ml) | IL-6 (pg/ml) | CRP (mg/l) | ESR (mm/h) | PA (g/l) |
|---|---|---|---|---|---|
| AdP (n=39) | 0.33±0.78 | 40.91±28.51 | 45.53±31.10 | 22.19±19.65 | 0.16±0.05 |
| CP (n=29) | 0.17±0.14 | 36.15±23.30 | 45.85±33.20 | 17.74±13.17 | 0.17±0.04 |
| SP (n=10) | 0.78±1.50 | 54.69±38.22 | 44.50±24.75 | 34.20±28.70 | 0.12±0.04 |
| URI (n=42) | 0.13±0.11 | 30.78±20.14 | 48.74±36.50 | 12.79±7.75 | 0.18±0.03 |
| ALL (n=81) | 0.23±0.56 | 35.72±24.95 | 47.21±33.87 | 17.43±15.50 | 0.17±0.04 |
p<0.01, AdP vs. URI;
p<0.01, SP vs. URI;
p<0.05, SP vs. CP.
PCT – procalcitonin; IL-6 – interleukin 6; CRP – C-reactive protein; ESR – erythrocyte sedimentation rate; PA – prealbumin; AdP – adenovirus pneumonia; CP – common pneumonia; SP – severe pneumonia; URI – upper respiratory infection.
Serum inflammatory marker concentrations in patients with and without co-infection.
| Marker | Without co-infection (n=63) | With co-infection (n=18) |
|---|---|---|
| PCT (ng/ml) | 0.17±0.16 | 0.44±1.14 |
| IL-6 (pg/ml) | 37.05±24.40 | 31.13±26.97 |
| ESR (mm/h) | 18.41±16.45 | 14.06±11.44 |
| CRP (mg/l) | 48.98±33.33 | 47.85±34.78 |
| PA (g/l) | 0.17±0.04 | 0.17±0.04 |
PCT – procalcitonin; IL-6 – interleukin 6; ESR – erythrocyte sedimentation rate; CRP – C-reactive protein; PA – prealbumin.
Figure 3Receiver operating characteristic (ROC) curves showing the diagnostic performance of inflammatory markers and the erythrocyte sedimentation rate (ESR) in distinguishing upper-respiratory infection from adenovirus pneumonia. PCT – procalcitonin; IL-6 – interleukin 6; CRP – C-reactive protein; PA – prealbumin.